Credit requests must be submitted within thirty days of the customer's order date. Pet Assistant reserves the right to audit all credit requests and investigate any issues before applying a credit to your account.
Osphos Injection contains clodronate to help horses with issues caused by navicular syndrome. It aids in symptom relief, slowing the disease's progression. The ready-to-use, easy-to-use vial does not require dilution.
What is Osphos Inj 60mg/mL, 15 ml?
OSPHOS is an injectable bisphosphonate solution for the control of clinical signs associated with navicular syndrome in horses four years and older. OSPHOS inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution), and by exerting direct cellular effects on osteoclasts. OSPHOS is supplied as 15 mL (900 mg) of clodronate disodium (60 mg/mL) per vial and is ready-to-use (no reconstitution or dilution required).
Who is Osphos Inj 60mg/mL, 15 ml for?
For use in horses ages 4 and up.
Why use Osphos Inj 60mg/mL, 15 ml?
Features of Osphos:
- Prevents bone resorption because it exerts direct effects on the cells of osteoclasts and binds to calcium phosphate crystals, which inhibits their dissolution and formation
- Excellent option for horses proven through radiography to have bony changes caused by navicular syndrome
- Injectable solution of bisphosphonate that aids in the control of the clinical signs of navicular syndrome
- The only option injected intramuscularly
- Contains 60mg clodronate in each mL
How does Osphos Inj 60mg/mL, 15 ml work?
Osphos works by inhibiting resorption of bone. It exerts direct effects on the cells of osteoclasts and binds to calcium phosphate crystals. This inhibits their dissolution and formation.
Osphos intramuscular injection contains the bisphosphonate Clodronic acid
How is Osphos Inj 60mg/mL, 15 ml sold?
Osphos Inj 60mg/mL is sold in 15ml - single use vial
What are the side effects of Osphos Inj 60mg/mL, 15 ml?
Field studies have shown that the most frequently-reported adverse reactions, which occurred within 2 hours of treatment, were:
After hand walking for 10-15 minutes, 8 out of the 10 horses with the symptoms listed above experience clinical sign resolution. One horse experienced resolution without any hand walking. Just one underwent treatment for colic. That particular horse also experienced hives, recovering following dexamethasone and flunixin treatment.
What special precautions are there?
Keep away from children.
What to do if overdose?
Immediately contact your closest emergency animal hospital.
How can I store Osphos Inj 60mg/mL, 15 ml?
Store in a dry and cool environment.
OSPHOS is administered at 1.8 mg/kg by intramuscular injection up to a maximum dose of 900 mg per horse (one vial). Divide the total volume evenly into three separate injection sites. Discard unused vial contents. OSPHOS is provided in a single use vial and does not contain a preservative. If there is no response to initial therapy, the horse should be re-evaluated. For horses that initially respond to OSPHOS but do not maintain their clinical improvement for 6 months, OSPHOS may be re-administered at 3 to 6 month intervals based on recurrence of clinical signs. For horses that respond to OSPHOS and maintain clinical improvement for 6 months, OSPHOS should be re-administered after clinical signs recur.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.